期刊
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
卷 52, 期 3-4, 页码 98-102出版社
WILEY-BLACKWELL
DOI: 10.1002/jlcr.1574
关键词
matrix metalloproteinase inhibitors; MMPI; ABT-518; 1-(methylsulfonyl)-4-[4-(trifluoromethoxy)phenoxy]benzene
A novel matrix metalloproteinase inhibitor, ABT-518, [S-(R*, R*)]-N-[1-(2, 2-dimethyl-1,3-dioxol-4-yl)-2-[[4-[4-(trifluoromethoxy)-phenoxy]phenyl]sulfonyl]ethyl]-N-hydroxyformamide, was labeled with tritium in two phenyl rings in a seven-step synthesis. The overall radiochemical yield of [H-3]ABT-518 in seven steps starting from 1-(methylsulfonyl)-4-[4-(trifluoromethoxy)phenoxy]benzene was 6.2% with the radiochemical purity of 99.4%.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据